325 related articles for article (PubMed ID: 34765020)
1. Perspectives on the diagnostic, predictive and prognostic markers of neuroendocrine neoplasms (Review).
Ciobanu OA; Martin S; Fica S
Exp Ther Med; 2021 Dec; 22(6):1479. PubMed ID: 34765020
[TBL] [Abstract][Full Text] [Related]
2. Neuroendocrine tumor biomarkers: From monoanalytes to transcripts and algorithms.
Modlin IM; Bodei L; Kidd M
Best Pract Res Clin Endocrinol Metab; 2016 Jan; 30(1):59-77. PubMed ID: 26971844
[TBL] [Abstract][Full Text] [Related]
3. Chromogranin A as circulating marker for diagnosis and management of neuroendocrine neoplasms: more flaws than fame.
Marotta V; Zatelli MC; Sciammarella C; Ambrosio MR; Bondanelli M; Colao A; Faggiano A
Endocr Relat Cancer; 2018 Jan; 25(1):R11-R29. PubMed ID: 29066503
[TBL] [Abstract][Full Text] [Related]
4. [Advances of circulating biomarkers in gastroenteropancreatic neuroendocrine neoplasms].
Chen L; Chen M; Chen J
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Mar; 20(3):357-360. PubMed ID: 28338171
[TBL] [Abstract][Full Text] [Related]
5. An Assessment of Circulating Chromogranin A as a Biomarker of Bronchopulmonary Neuroendocrine Neoplasia: A Systematic Review and Meta-Analysis.
Malczewska A; Kidd M; Matar S; Kos-Kudła B; Bodei L; Oberg K; Modlin IM
Neuroendocrinology; 2020; 110(3-4):198-216. PubMed ID: 31266019
[TBL] [Abstract][Full Text] [Related]
6. The Quest for Circulating Biomarkers in Neuroendocrine Neoplasms: a Clinical Perspective.
Mariën L; Islam O; Chhajlani S; Lybaert W; Peeters M; Van Camp G; Op de Beeck K; Vandamme T
Curr Treat Options Oncol; 2023 Dec; 24(12):1833-1851. PubMed ID: 37989978
[TBL] [Abstract][Full Text] [Related]
7. Gastroenteropancreatic neuroendocrine neoplasms: A clinical snapshot.
Fernandez CJ; Agarwal M; Pottakkat B; Haroon NN; George AS; Pappachan JM
World J Gastrointest Surg; 2021 Mar; 13(3):231-255. PubMed ID: 33796213
[TBL] [Abstract][Full Text] [Related]
8. Clinical applications of (epi)genetics in gastroenteropancreatic neuroendocrine neoplasms: Moving towards liquid biopsies.
Boons G; Vandamme T; Peeters M; Van Camp G; Op de Beeck K
Rev Endocr Metab Disord; 2019 Sep; 20(3):333-351. PubMed ID: 31368038
[TBL] [Abstract][Full Text] [Related]
9. Prospective Evaluation of the NETest as a Liquid Biopsy for Gastroenteropancreatic and Bronchopulmonary Neuroendocrine Tumors: An ENETS Center of Excellence Experience.
Malczewska A; Witkowska M; Wójcik-Giertuga M; Kuśnierz K; Bocian A; Walter A; Rydel M; Robek A; Pierzchała S; Malczewska M; Leś-Zielińska I; Czyżewski D; Ziora D; Pilch-Kowalczyk J; Zajęcki W; Kos-Kudła B
Neuroendocrinology; 2021; 111(4):304-319. PubMed ID: 32335553
[TBL] [Abstract][Full Text] [Related]
10. Blood Chromogranin A Is Not Effective as a Biomarker for Diagnosis or Management of Bronchopulmonary Neuroendocrine Tumors/Neoplasms.
Matar S; Malczewska A; Oberg K; Bodei L; Aslanian H; Lewczuk-Myślicka A; Filosso PL; Suarez AL; Kolasińska-Ćwikła A; Roffinella M; Kos-Kudła B; Ćwikła JB; Drozdov IA; Kidd M; Modlin IM
Neuroendocrinology; 2020; 110(3-4):185-197. PubMed ID: 30995665
[TBL] [Abstract][Full Text] [Related]
11. Chromogranin A in diagnosing and monitoring patients with gastroenteropancreatic neuroendocrine neoplasms: a large series from a single institution.
Massironi S; Rossi RE; Casazza G; Conte D; Ciafardini C; Galeazzi M; Peracchi M
Neuroendocrinology; 2014; 100(2-3):240-9. PubMed ID: 25428270
[TBL] [Abstract][Full Text] [Related]
12. The identification of gut neuroendocrine tumor disease by multiple synchronous transcript analysis in blood.
Modlin IM; Drozdov I; Kidd M
PLoS One; 2013; 8(5):e63364. PubMed ID: 23691035
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic work-up and advancement in the diagnosis of gastroenteropancreatic neuroendocrine neoplasms.
Koffas A; Giakoustidis A; Papaefthymiou A; Bangeas P; Giakoustidis D; Papadopoulos VN; Toumpanakis C
Front Surg; 2023; 10():1064145. PubMed ID: 36950054
[TBL] [Abstract][Full Text] [Related]
14. A Delphic consensus assessment: imaging and biomarkers in gastroenteropancreatic neuroendocrine tumor disease management.
Oberg K; Krenning E; Sundin A; Bodei L; Kidd M; Tesselaar M; Ambrosini V; Baum RP; Kulke M; Pavel M; Cwikla J; Drozdov I; Falconi M; Fazio N; Frilling A; Jensen R; Koopmans K; Korse T; Kwekkeboom D; Maecke H; Paganelli G; Salazar R; Severi S; Strosberg J; Prasad V; Scarpa A; Grossman A; Walenkamp A; Cives M; Virgolini I; Kjaer A; Modlin IM
Endocr Connect; 2016 Sep; 5(5):174-87. PubMed ID: 27582247
[TBL] [Abstract][Full Text] [Related]
15. Neuroendocrine neoplasms: current and potential diagnostic, predictive and prognostic markers.
Herrera-Martínez AD; Hofland LJ; Gálvez Moreno MA; Castaño JP; de Herder WW; Feelders RA
Endocr Relat Cancer; 2019 Mar; 26(3):R157-R179. PubMed ID: 30615596
[TBL] [Abstract][Full Text] [Related]
16. Molecular identification of bronchopulmonary neuroendocrine tumours and neuroendocrine genotype in lung neoplasia using the NETest liquid biopsy.
Filosso PL; Öberg K; Malczewska A; Lewczuk A; Roffinella M; Aslanian H; Bodei L
Eur J Cardiothorac Surg; 2020 Jun; 57(6):1195-1202. PubMed ID: 32047924
[TBL] [Abstract][Full Text] [Related]
17. An Overview of Circulating Biomarkers in Neuroendocrine Neoplasms: A Clinical Guide.
Bevere M; Masetto F; Carazzolo ME; Bettega A; Gkountakos A; Scarpa A; Simbolo M
Diagnostics (Basel); 2023 Aug; 13(17):. PubMed ID: 37685358
[TBL] [Abstract][Full Text] [Related]
18. Circulating tumor cells and miRNAs as prognostic markers in neuroendocrine neoplasms.
Zatelli MC; Grossrubatscher EM; Guadagno E; Sciammarella C; Faggiano A; Colao A
Endocr Relat Cancer; 2017 Jun; 24(6):R223-R237. PubMed ID: 28389504
[TBL] [Abstract][Full Text] [Related]
19. Pretreatment Levels of Chromogranin A and Neuron-specific Enolase in Patients With Gastroenteropancreatic Neuroendocrine Neoplasia.
Kečkéš Š; Palaj J; Waczulíková I; Dyttert D; Mojtová E; Kováč G; Durdík Š
In Vivo; 2021; 35(5):2863-2868. PubMed ID: 34410979
[TBL] [Abstract][Full Text] [Related]
20. Prognostic stratification of metastatic gastroenteropancreatic neuroendocrine neoplasms by 18F-FDG PET: feasibility of a metabolic grading system.
Ezziddin S; Adler L; Sabet A; Pöppel TD; Grabellus F; Yüce A; Fischer HP; Simon B; Höller T; Biersack HJ; Nagarajah J
J Nucl Med; 2014 Aug; 55(8):1260-6. PubMed ID: 24876204
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
